BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31167243)

  • 1. [Personalised medicine in renal cell tumours].
    Junker K; Zeuschner P
    Aktuelle Urol; 2019 Sep; 50(5):513-523. PubMed ID: 31167243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors and prognostic models for renal cell carcinoma: a literature review.
    Klatte T; Rossi SH; Stewart GD
    World J Urol; 2018 Dec; 36(12):1943-1952. PubMed ID: 29713755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards individualized therapy for metastatic renal cell carcinoma.
    Kotecha RR; Motzer RJ; Voss MH
    Nat Rev Clin Oncol; 2019 Oct; 16(10):621-633. PubMed ID: 30992569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Personalized Management of Advanced Kidney Cancer.
    Graham J; Heng DYC; Brugarolas J; Vaishampayan U
    Am Soc Clin Oncol Educ Book; 2018 May; 38():330-341. PubMed ID: 30231375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renal cell carcinoma in older and geriatric patients].
    Wagener N
    Urologe A; 2017 Aug; 56(8):1019-1024. PubMed ID: 28451746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Possibilities of molecular diagnosis of renal cell carcinoma].
    Junker K
    Aktuelle Urol; 2014 Sep; 45(5):370-3. PubMed ID: 25230022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic approaches in clear cell and non-clear cell renal cell carcinoma.
    Vermassen T; De Meulenaere A; Van de Walle M; Rottey S
    Acta Clin Belg; 2017 Feb; 72(1):12-18. PubMed ID: 27356035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Active surveillance for renal cell carcinoma].
    Doehn C; Witzsch U; Siebels M
    Aktuelle Urol; 2012 Jul; 43(4):243-9. PubMed ID: 22869494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genomics of renal cell carcinoma and its role in renal mass biopsy.
    Salami SS; George AK; Udager AM
    Curr Opin Urol; 2018 Jul; 28(4):383-391. PubMed ID: 29708949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Novel biomarkers in renal cell carcinoma. Identification and functional characterization].
    Macher-Göppinger S
    Pathologe; 2015 Nov; 36 Suppl 2():201-4. PubMed ID: 26362327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genitourinary imaging: part 2, role of imaging in medical management of advanced renal cell carcinoma.
    Shinagare AB; Krajewski KM; Jagannathan JP; Ramaiya NH
    AJR Am J Roentgenol; 2012 Nov; 199(5):W554-64. PubMed ID: 23096199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of adjuvant immunotherapy in renal cell carcinoma.
    Mulders PF; De Mulder PH
    Curr Urol Rep; 2002 Feb; 3(1):44-9. PubMed ID: 12084219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronous primary cancers: Renal cell carcinoma and rectal cancer.
    Babu MCS; Asati V; Babu KG; Suma MN; Rajeev LK; Lokesh KN
    J Cancer Res Ther; 2019; 15(1):250-251. PubMed ID: 30880786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On-treatment biomarkers in metastatic renal cell carcinoma: towards individualization of prognosis?
    Donskov F; Heng DY; Rini BI
    Expert Rev Anticancer Ther; 2017 Feb; 17(2):97-99. PubMed ID: 27927054
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnostic and prognostic markers of renal cell carcinoma].
    Spadaccino F; Netti GS; Rocchetti MT; Castellano G; Stallone G; Ranieri E
    G Ital Nefrol; 2020 Apr; 37(2):. PubMed ID: 32281759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment of renal cancer: new horizons.
    Greef B; Eisen T
    Br J Cancer; 2016 Aug; 115(5):505-16. PubMed ID: 27490806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic markers in renal cell carcinoma.
    Ljungberg B
    Curr Opin Urol; 2007 Sep; 17(5):303-8. PubMed ID: 17762621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic Features and Prognosis of Sporadic Bilateral Renal Cell Carcinoma: A Series of 148 Cases.
    Qi N; Li T; Ning X; Peng X; Cai L; Gong K
    Clin Genitourin Cancer; 2017 Oct; 15(5):618-624. PubMed ID: 28648756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.